Invention Grant
- Patent Title: (Trifluoromethyl)pyrimidine-2-amine compounds
-
Application No.: US17872185Application Date: 2022-07-25
-
Publication No.: US11773067B2Publication Date: 2023-10-03
- Inventor: Daryl Lynn Smith , Leonard Larry Winneroski, Jr.
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Robert D. Shereda
- Main IPC: C07D239/47
- IPC: C07D239/47 ; A61K31/505
Abstract:
The present invention provides a compound of Formula I:
wherein R1 is hydrogen or methyl; and
R2 is:
or a pharmaceutically acceptable salt thereof, useful for treating pain, including chronic pain, chronic lower back pain, diabetic peripheral neuropathic pain, and osteoarthritis pain.
wherein R1 is hydrogen or methyl; and
R2 is:
or a pharmaceutically acceptable salt thereof, useful for treating pain, including chronic pain, chronic lower back pain, diabetic peripheral neuropathic pain, and osteoarthritis pain.
Public/Granted literature
- US20220372003A1 (TRIFLUOROMETHYL)PYRIMIDINE-2-AMINE COMPOUNDS Public/Granted day:2022-11-24
Information query
